prostate cancer gene therapy (GenStar/Baxter)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprostate cancer gene therapy (GenStar/Baxter)

Drug Alias NameDUAL-AD vector systemIL-3 gene therapy (GenStar/Baxter)prostate cancer gene therapy (Corautus/Baxter)interleukin-3 gene therapy (Corautus/Baxter)IL-3 gene therapy (Corautus/Baxter) +[8]

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccineCell and gene therapy > Gene therapy > Viral vector-based gene therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVia Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVia Pharmaceuticals

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A